Canada - English - Health Canada

auro pharma inc - cefuroxime (cefuroxime axetil) - tablet - 500mg - cefuroxime (cefuroxime axetil) 500mg - second generation cephalosporins

United States - English - NLM (National Library of Medicine)

h.j. harkins company, inc. - cefuroxime axetil (unii: z49qdt0j8z) (cefuroxime - unii:o1r9fj93ed) - cefuroxime 500 mg -   - pharyngitis/tonsillitis caused by streptococcus pyogenes.   note: the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. cefuroxime axetil tablets are generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cefuroxime in the subsequent prevention of rheumatic fever are not available. please also note that in all clinical trials, all isolates had to be sensitive to both penicillin and cefuroxime. there are no data from adequate and well-controlled trials to demonstrate the effectiveness of cefuroxime in the treatment of penicillin-resistant strains of streptococcus pyogenes.   - acute bacterial otitis media caused by streptococcus pneumoniae , haemophilus influenzae (including beta-lactamase–producing strains), moraxella catarrhalis (including beta-lactamase–producing strains), or streptococcu

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - cefuroxime axetil - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - cefuroxime axetil - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - cefuroxime axetil - oral tablet - 250mg

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - cefuroxime sodium - powder for solution for injection/infusion - 1.5 gram(s) - second-generation cephalosporins; cefuroxime

Israel - English - Ministry of Health

a.l. medi-market ltd. - cefuroxime as sodium - powder for solution for inj/inf - cefuroxime as sodium 750 mg/vial - cefuroxime - cefuroxime medo is indicated for the treatment of the infections listed below in adults and children, including neonates (from birth)• community acquired pneumonia• acute exacerbations of chronic bronchitis• complicated urinary tract infections, including pyelonephritis• soft-tissue infections: cellulitis, erysipelas and wound infections• intra-abdominal infections • prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic, cardiovascular, and gynaecological surgery (including caesarean section) • nose infections for example, sinusitis • septic arthritis

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cefuroxime sodium 1578mg equivalent to 1500 mg cefuroxime;   - powder for injection - 1.5 g - active: cefuroxime sodium 1578mg equivalent to 1500 mg cefuroxime   - cefuroxime-aft is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. indications include: · respiratory tract infections e.g. acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cefuroxime sodium 263mg equivalent to 250 mg cefuroxime;   - powder for injection - 250 mg - active: cefuroxime sodium 263mg equivalent to 250 mg cefuroxime   - cefuroxime-aft is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. indications include: · respiratory tract infections e.g. acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cefuroxime sodium 789mg equivalent to 750 mg cefuroxime;   - powder for injection - 750 mg - active: cefuroxime sodium 789mg equivalent to 750 mg cefuroxime   - cefuroxime-aft is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. indications include: · respiratory tract infections e.g. acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections.